Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
Titel:
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
Auteur:
Burger, Jan A Keating, Michael J Wierda, William G Hartmann, Elena Hoellenriegel, Julia Rosin, Nathalie Y de Weerdt, Iris Jeyakumar, Ghayathri Ferrajoli, Alessandra Cardenas-Turanzas, Marylou Lerner, Susan Jorgensen, Jeffrey L Nogueras-González, Graciela M Zacharian, Gracy Huang, Xuelin Kantarjian, Hagop Garg, Naveen Rosenwald, Andreas O'Brien, Susan